Skip to main content
Clinical Trials/NCT03631758
NCT03631758
Completed
Not Applicable

McMaster Choices Study: Evaluating the Impact of Cancer Screening Patient Decision Aids on Breast Cancer Screening Decisions

McMaster University1 site in 1 country209 target enrollmentJanuary 1, 2019
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
McMaster University
Enrollment
209
Locations
1
Primary Endpoint
Decisional Conflict Scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by women facing breast cancer screening decisions.

Detailed Description

Guidelines for breast screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that assist users to understand treatment options, risks and benefits to align decisions with values and preferences. The investigators would now like to know whether use of a PDA alongside evidence-based information provided through the McMaster Optimal Aging Portal, or simply access to evidence-based information alone, can help users to make informed decisions about breast cancer screening in women.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 1, 2020
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English speaking women, 40-49 years old
  • Residents of British Columbia, Nova Scotia, and Prince Edward Island

Exclusion Criteria

  • History of breast cancer or mammography in the last 12 months
  • Classified as above-average risk for breast cancer (i.e., known genetic mutation linked to BC; no genetic testing, but a parent, sibling or child with a genetic mutation linked to BC; or received chest wall radiation before age 30)

Outcomes

Primary Outcomes

Decisional Conflict Scale

Time Frame: Change from baseline to 6-mo

A validated scale in which items are summed and scored to create a total score. Scores range from 0 to 100, with higher scores indicating higher decisional conflict.

Secondary Outcomes

  • Preparation for Decision Making Scale(Change from baseline to 6-mo)
  • Screening behaviour(Change from baseline to 6-mo)
  • Decision quality(Change from baseline to 6-mo)

Study Sites (1)

Loading locations...

Similar Trials